Advancement of antigen-specific immunotherapy: knowledge transfer between allergy and autoimmunity

Research output: Contribution to journalArticlepeer-review

79 Downloads (Pure)


Targeted restoration of immunological tolerance to self-antigens or innocuous environmental allergens represents the ultimate aim of treatment options in autoimmune and allergic disease. Antigen-specific immunotherapy (ASI) is the only intervention that has proven disease-modifying efficacy as evidenced by induction of long-term remission in a number of allergic conditions. Mounting evidence is now indicating that specific targeting of pathogenic T cells in autoinflammatory and autoimmune settings enables effective restoration of immune homeostasis between effector and regulatory cells and alters the immunological course of disease. Here, we discuss the key lessons learned during the development of antigen-specific immunotherapies and how these can be applied to inform future interventions. Armed with this knowledge and current high-throughput technology to track immune cell phenotype and function, it may no longer be a matter of ‘if’ but ‘when’ this ultimate aim of targeted tolerance restoration is realised.
Original languageEnglish
Article numberltab009
JournalImmunotherapy Advances
Issue number1
Early online date22 May 2021
Publication statusPublished - 2021


  • immunotherapy
  • immune tolerance
  • allergy
  • autoimmunity
  • immunoregulation


Dive into the research topics of 'Advancement of antigen-specific immunotherapy: knowledge transfer between allergy and autoimmunity'. Together they form a unique fingerprint.

Cite this